(Q39649197)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20886599%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

The antimalarial agent artesunate possesses anticancer properties that can be enhanced by combination strategies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20886599%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20886599%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Andrew M Gravett

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20886599%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Angus G Dalgleish

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20886599%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

language of work or name

English

0 references

publication date

28 November 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20886599%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

14 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20886599%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

128

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20886599%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20886599%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

1471-1480

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20886599%20AND%20SRC:MED&resulttype=core&format=json

Randomised comparative study of mefloquine, qinghaosu, and pyrimethamine-sulfadoxine in patients with falciparum malaria

14 February 2020

cites work

1 reference

Artemisinins: their growing importance in medicine

21 January 2018

1 reference

Artemisinin: mechanisms of action, resistance and toxicity

21 January 2018

1 reference

Current perspectives on the mechanism of action of artemisinins

21 January 2018

1 reference

Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells

21 January 2018

1 reference

From traditional Chinese medicine to rational cancer therapy.

21 January 2018

1 reference

Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo

21 January 2018

1 reference

Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo

21 January 2018

1 reference

In vitro study of the anti-cancer effects of artemisone alone or in combination with other chemotherapeutic agents

21 January 2018

1 reference

Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines

21 January 2018

1 reference

Experimental Therapy of Hepatoma with Artemisinin and Its Derivatives: In vitro and In vivo Activity, Chemosensitization, and Mechanisms of Action

21 January 2018

1 reference

Dihydroartemisinin induces apoptosis in human leukemia cells HL60 via downregulation of transferrin receptor expression

21 January 2018

1 reference

First evidence that the antimalarial drug artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases

21 January 2018

1 reference

Effect of artesunate on inhibiting proliferation and inducing apoptosis of SP2/0 myeloma cells through affecting NFkappaB p65.

21 January 2018

1 reference

Artesunate protects sepsis model mice challenged with Staphylococcus aureus by decreasing TNF-alpha release via inhibition TLR2 and Nod2 mRNA expressions and transcription factor NF-kappaB activation

21 January 2018

1 reference

Enhancing the cytotoxic activity of novel targeted therapies--is there a role for a combinatorial approach?

21 January 2018

1 reference

Combination treatment of glioblastoma multiforme cell lines with the anti-malarial artesunate and the epidermal growth factor receptor tyrosine kinase inhibitor OSI-774.

21 January 2018

1 reference

Enhancing the in vitro cytotoxic activity of Delta9-tetrahydrocannabinol in leukemic cells through a combinatorial approach

21 January 2018

1 reference

The importance of drug scheduling and recovery phases in determining drug activity. Improving etoposide efficacy in BCR-ABL-positive CML cells

21 January 2018

1 reference

Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu).

21 January 2018

1 reference

Artesunate derived from traditional Chinese medicine induces DNA damage and repair.

21 January 2018

1 reference

Selective resistance of tetraploid cancer cells against DNA damage-induced apoptosis

21 January 2018

1 reference

Tetraploidy, aneuploidy and cancer

21 January 2018

1 reference

Steady-state regulation of the human DNA mismatch repair system.

21 January 2018

1 reference

Spectral karyotyping suggests additional subsets of colorectal cancers characterized by pattern of chromosome rearrangement.

21 January 2018

1 reference

Loss of MSH3 protein expression is frequent in MLH1-deficient colorectal cancer and is associated with disease progression.

21 January 2018

1 reference

Molecular basis to understand polyploidy

21 January 2018

1 reference

Endoreplication: polyploidy with purpose

21 January 2018

1 reference